Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Vaporox Inc. logo — Revolutionizing Wound Care Through the Power of Vaporous Hyp...

Vaporox Inc.

Revolutionizing Wound Care Through the Power of Vaporous Hyperoxia Therapy (VHT™)

Founded 2016 United States Denver, United States 18 employees Series A Total: $9.68M Health Care, Medical Devices

General Information

Company Name Vaporox Inc.
Founded Year 2016
Location United States Denver, United States +1
Employees 18
Industries Health Care, Medical Devices
Funding Stage Series A
Social

Get notified when Vaporox Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Vaporox Inc.

Vaporox Inc. is a health care startup founded in 2016, headquartered in the United States. The company's slogan, "Breakthrough technology for treating skin wounds," encapsulates its focus on addressing the significant challenge of non-healing skin wounds which impose substantial costs and human suffering. For instance, diabetic foot ulcers (DFUs) alone result in 108,000 lower limb amputations annually in the U.S., with estimated economic costs of $14.8 billion/year. Vaporox, Inc. has developed Vaporous Hyperoxia Therapy (VHT™), a new, patented, and FDA-510K-cleared technology capable of treating 7 different types of skin wounds. The technology, which utilizes ultrasonic waves to create microscopic particles containing water and an anti-microbial, has demonstrated substantial efficacy through real-world data from observational studies. Impressively, VHT has healed 90.7% of DFUs that had previously resisted standard wound care treatment, while also reducing costs compared to less-effective methods. Looking ahead, Vaporox is gearing up to commence a new round of field trials focused on healing DFUs and pressure ulcers in early 2019. The company's progress has attracted substantial investment, with a $2.00M Series A investment received on 01 August 2022. Overall, Vaporox Inc. is positioned at the forefront of advancing wound care technology, offering a compelling solution to a pressing health challenge with noteworthy potential for both financial return and societal impact.

Taxonomy: Medical Technology, Wound Healing, Vaporous Hyperoxia Therapy, Healthcare Innovation, Diabetic Foot Ulcers, Pressure Ulcers, FDA-510K-cleared, Observational Studies, Field Trials, Ultrasonic Waves, Microscopic Particles, Antimicrobial Technology, Patient Comfort, Chronic Wound Treatment, Healthcare Cost Reduction

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• - 01 Aug 2022
Corporate Round •••••• 1
Investor
24 Jun 2021
Seed Round •••••• 1
Investor
01 Apr 2020
Seed Round •••••• 1
Investor
01 Sep 2019
Seed Round •••••• 1
Investor
29 Mar 2019

Vaporox Inc. Alternatives & Competitors

Vaporox Inc. vs
Rapid Nexus Nanotech Wound Solutions, Inc.
Rapid Nexus Nanotech Wound Solutions, Inc. United States

The first company to develop a novel peripheral neuropathy tissue healing product.

6 employees
Biotechnology, Health Care
Vaporox Inc. vs
Inochi Care
Inochi Care India

innovating healthcare

5 employees
Vaporox Inc. vs
Reapplix
Reapplix Denmark

Every wound is personal

Series A
29 employees
Biotechnology, Health and Wellness

FAQ About Vaporox Inc.

Revolutionizing Wound Care Through the Power of Vaporous Hyperoxia Therapy (VHT™)
Vaporox Inc. was founded in 2016.
Vaporox Inc. is headquartered in Denver, United States.
Vaporox Inc. operates in the following industries: Health Care, Medical Devices.
Vaporox Inc. has approximately 18 employees.
Vaporox Inc. has completed 5 funding rounds, raising a total of $9.68M. The latest funding stage is Series A.
Top alternatives and competitors to Vaporox Inc. include Rapid Nexus Nanotech Wound Solutions, Inc., Inochi Care, Reapplix, R3 Wound Care and Hyperbarics, SilverStream Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vaporox Inc. and Rapid Nexus Nanotech Wound Solutions, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Vaporox Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy